Paper42179772
An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications.
Vats P and 6 others. Biomater Transl, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications. Papers, record 42179772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42179772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References355
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34963897 | Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34963897 | PubMed |
| 2 | 27672148 | CRISPR-Cas: biology, mechanisms and relevance. | Philos Trans R Soc Lond B Biol Sci | 2016 | https://conductscience.org/library/papers/27672148 | PubMed |
| 3 | 31901636 | Sharpening the Molecular Scissors: Advances in Gene-Editing Technology. | iScience | 2020 | https://conductscience.org/library/papers/31901636 | PubMed |
| 4 | 37026505 | Advances in the application of molecular diagnostic techniques for the detection of infectious disease pathogens (Review). | Mol Med Rep | 2023 | https://conductscience.org/library/papers/37026505 | PubMed |
| 5 | 35810160 | Programmable CRISPR-Cas9 microneedle patch for long-term capture and real-time monitoring of universal cell-free DNA. | Nat Commun | 2022 | https://conductscience.org/library/papers/35810160 | PubMed |
| 6 | 36508352 | CRISPR-Based Diagnostics: Challenges and Potential Solutions toward Point-of-Care Applications. | ACS Synth Biol | 2023 | https://conductscience.org/library/papers/36508352 | PubMed |
| 7 | 24481216 | E-CRISP: fast CRISPR target site identification. | Nat Methods | 2014 | https://conductscience.org/library/papers/24481216 | PubMed |
| 8 | 24779710 | Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy. | Chem Rev | 2014 | https://conductscience.org/library/papers/24779710 | PubMed |
| 9 | 36796171 | A visual CRISPR/dCas9-mediated enzyme-linked immunosorbent assay for nucleic acid detection with single-base specificity. | Talanta | 2023 | https://conductscience.org/library/papers/36796171 | PubMed |
| 10 | 39033781 | Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/39033781 | PubMed |
| 11 | 33570401 | Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection. | Anal Chem | 2021 | https://conductscience.org/library/papers/33570401 | PubMed |
| 12 | 37469443 | Deep learning in CRISPR-Cas systems: a review of recent studies. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37469443 | PubMed |
| 13 | 34243775 | The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34243775 | PubMed |
| 14 | 33529861 | A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics. | Biosens Bioelectron | 2021 | https://conductscience.org/library/papers/33529861 | PubMed |
| 15 | 33097693 | Prime editing for functional repair in patient-derived disease models. | Nat Commun | 2020 | https://conductscience.org/library/papers/33097693 | PubMed |
| 16 | 36843874 | Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets. | Appl Biol Chem | 2023 | https://conductscience.org/library/papers/36843874 | PubMed |
| 17 | 32807807 | Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. | Nat Commun | 2020 | https://conductscience.org/library/papers/32807807 | PubMed |
| 18 | 40699869 | Integrating Artificial Intelligence in Next-Generation Sequencing: Advances, Challenges, and Future Directions. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699869 | PubMed |
| 19 | 38881649 | Revolutionizing biomedicine: Aptamer-based nanomaterials and nanodevices for therapeutic applications. | Biotechnol Rep (Amst) | 2024 | https://conductscience.org/library/papers/38881649 | PubMed |
| 20 | 29267886 | Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29267886 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650936 | Advancements in CRISPR/Cas Technologies for Sensitive Cancer Detection: Mechanisms, Platforms, and Clinical Translation Roadmap. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42650936 | PubMed |
| 42455481 | Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/42455481 | PubMed |
| 41521358 | CRISPR Applications in HIV Management - Prevention, Diagnosis, Monitoring and Treatment. | Curr HIV/AIDS Rep | 2026 | https://conductscience.org/library/papers/41521358 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42179772
GET https://conductscience.org/api/papers/v1/42179772/references?page=2